1951
DOI: 10.1016/s0140-6736(51)91121-x
|View full text |Cite
|
Sign up to set email alerts
|

Preservation of Typhoid Vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1951
1951
1975
1975

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…The results so far described were obtained with strain Ty2 as the test culture. This strain had been selected for this study, since on the basis of laboratory criteria, acetone-killed suspensions of these cells have been demonstrated to be superior vaccines (Henderson et al, 1951, Landy, 1953. Nevertheless, heat-killed, phenol-preserved vaccines prepared from S. typhosa strain V58 are widely used for immunization.…”
Section: Descriptiono Enitrogenmentioning
confidence: 99%
“…The results so far described were obtained with strain Ty2 as the test culture. This strain had been selected for this study, since on the basis of laboratory criteria, acetone-killed suspensions of these cells have been demonstrated to be superior vaccines (Henderson et al, 1951, Landy, 1953. Nevertheless, heat-killed, phenol-preserved vaccines prepared from S. typhosa strain V58 are widely used for immunization.…”
Section: Descriptiono Enitrogenmentioning
confidence: 99%
“…cine may be expected to retain potency well beyond this limit. One vaccine was found potent after 15 years (3,4). No mention of pH control has been observed in reports of potency loss related to age and/or storage conditions (3,4,6,9,10).…”
Section: Resultsmentioning
confidence: 99%
“…This vaccine, in a concentration of 2000 million organisms per ml. in 0-01 % merthiolate, was divided in two portions: while one portion was stored in a refrigerator at a temperature of 4-60 C., the other half was kept at a temperature of 410 C. for 12 months to study the effects of improper and unfavourable storage conditions on this vaccine (accelerated ageing, Landy, 1953;Henderson, Peacock & Rickley, 1951).…”
Section: In Vivo Experimentsmentioning
confidence: 99%